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AbstrAct:
Hemorrhagic fever with renal syndrome (HFRS) is widely distributed in Europe and caused mostly by 
two different orthohantaviruses: Puumala virus (PUUV) and Dobrava virus (DOBV). Several studies 
have implicated that HFRS is an immunologically mediated disease and that the proinflammatory 
cytokines may have a role in the immunopathogenesis of HFRS. In this study, we have detected: IL-2; 
IL-6; their soluble receptors (sIL-2R, sIL-6R); TNF-alpha; sCD23; and total IgE in two consecutive 
sera of HFRS patients, and have looked for their possible relation with the main blood and biochem-
ical findings in order to determine their possible role in disease progression. The differences in the 
level of measured parameters between PUUV- and DOBV-infected patients were also observed. The 
sIL-2R, sIL-6R and sCD23 levels were elevated in all HFRS patients, but we did not find any statistical 
difference between 1st and 2nd sera. The total IgE was elevated in about 1/3 of HFRS patients in both 
sera. We detected higher IL-6, sIL-2R and sCD23 levels in the sera of patients with DOBV infection 
than in patients with PUUV infection, with no statistically significant difference. The total IgE level was 
elevated in five of the six tested patients with DOBV infection, and they had a statistically higher level 
of total IgE than patients with PUUV infection. Almost all the listed biochemical and blood parameters 
in HFRS patients stand either in positive or in negative correlation with sIL-2Rapha. The levels of urea 
and creatinine, which are the hallmarks of HFRS severity, stand in positive correlation with sIL-2Ra-
pha, IL-6, sIL-6R and sCD23. The level of the total IgE stands either in positive or in negative correla-
tion with proteins and parameters of the liver function. We have also found a high positive correlation 
between the total IgE level and basophile count.
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Sažetak:
Hemoragijska vrućica s bubrežnim sindromom (HVBS) široko je rasprostranjena u Europi, a uzroko-
vana je uglavnom dvjema različitim ortohantavirusima: virusom Puumala (PUUV) i virusom Dobrava 
(DOBV). Nekoliko studija implicira da je HVBS imunološki posredovana bolest i da proinflamatorni 
citokini mogu imati ulogu u imunopatogenezi HFRS. U ovoj smo studiji određivali: IL-2, IL-6, njihove 
solubilne receptore (sIL-2R, sIL-6R), TNF-alfa, sCD23 i ukupni IgE u dva uzastopna seruma pacijena-
ta s HVBS-om i tražili njihovu moguću vezu s glavnim hematološkim i biokemijskim nalazima, kako bi 
se utvrdila njihova moguća uloga u progresiji bolesti. Također su analizirane razlike u razini izmjerenih 
parametara između bolesnika inficiranih PUUV i DOBV. U svih bolesnika s HVBS-om, razine sIL-2R, 
sIL-6R i sCD23 su bile povišene, ali nismo pronašli statističku razliku između prvog i drugog seruma. 
Ukupni IgE je povišen u oko 1/3 HFRS pacijenata u oba seruma. U serumu bolesnika s DOBV-infekci-
jom utvrđene su više razine IL-6, sIL-2R i sCD23 nego u bolesnika s PUUV- infekcijom, bez statistički 
značajne razlike. Ukupna razina IgE bila je povišena u pet od šest testiranih bolesnika s DOBV-infekci-
jom i imali su statistički značajno višu razinu ukupnog IgE od bolesnika s PUUV-infekcijom. Gotovo 
svi navedeni biokemijski i hematološki parametri u HVBS-bolesnika su u pozitivnoj ili negativnoj 
korelaciji sa sIL-2R. Razine ureje i kreatinina, koje su obilježja težine HVBS-a, su u pozitivnoj korel-
aciji sa sIL-2Ra, IL-6, sIL-6R i sCD23. Razina ukupnog IgE je u pozitivnoj ili negativnoj korelaciji s 
proteinima i parametrima funkcije jetre. Utvrdili smo i visoku pozitivnu korelaciju između ukupnog 
IgE i bazofila.
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introduction 
The most important genus of the family Hantaviridae is ortho-
hantavirus (HTV), which now comprises 36 viral species1. This 
group of RNA viruses is related to two different syndromes: 
hemorrhagic fever with renal syndrome (HFRS) and hantavirus 
pulmonary syndrome (HPS)2.  HFRS is widely distributed in 
Europe and caused mostly with two different HTV: Puumala vi-
rus (PUUV) usually causes mild or moderate HFRS disease and 
Dobrava virus (DOBV), which is usually associated with severe 
disease, but exceptions are also reported 3, 4, 5. 
Following the incubation period, HFRS is manifested mainly 
by fever, variable degrees of circulatory failure, hemorrhage and 
renal failure, but the symptoms demonstrating the involvement 
of other organs and systems are also observed3,4,5. As there is a 
considerable variation among patients in the clinical manifes-
tations of the disease, an attempt was made to link the type of 
hantavirus (HTV) with the severity of the disease, but also to 
put it in the relationship with some genetic and/or immunolog-
ical characteristics. There is evidence that the severity of HFRS 
caused by Puumala virus is associated with a certain HLA haplo-
type6. The study of the pathogenesis of HFRS in vivo is limited 
by the lack of a suitable animal model7, so the mechanisms 
underlying the induction of HFRS symptoms and manifestations 
are largely unknown. Several studies support the view that HFRS 
is an immunologically mediated disease with thrombocytopenia 
and vascular dysfunction (mainly due to capillary leakage) as the 
central physiologic derangement5, 7, 8. 
Some studies have implicated that the proinflammatory cyto-
kines: interleukin (IL)-1, IL-6 and tumor necrosis factor alpha 
(TNF-a) may have a role in the immunopathogenesis of HFRS 
9,10,11,12. Khaiboullina et al., recently showed distinct cytokine 
profiles between HFRS and HPS13.  The role of soluble CD23 
(sCD23) and immunoglobulin E (IgE) in HFRS immunopatho-
genesis was also considered of importance14,15,16. The possible im-
portance of sIL-2 receptor (sIL-2R) and its potential correlation 
with some clinical laboratory parameters and severity of HFRS 
in patients infected with Puumala or Hantaan (HTNV) virus has 
also been presented11,17,18,19. 
In this study, we detected: IL-2, IL-6, their soluble receptors 
(sIL-2R, sIL-6R), TNF-alpha, sCD23 and total IgE in two 
consecutive sera of HFRS patients and looked for their possi-
ble relation with the main blood and biochemical findings in 
order to determine their possible role in disease progression. The 
differences in the level of measured parameters between PUUV 
and DOBV infected patients were also observed for the purpose 
of analyzing their role in the distinction of patients infected with 
one of the viruses and eventual association with the severity of 
clinical picture.
PatientS and MethodS 
The information about the number of tested patients and the 
sera collected during the HFRS course (at admission and before 
dismission to the hospital), the day of blood collection and the 
tested immunological parameters are described in table 1. The 
patients were hospitalized in few clinical centers in Croatia. Spe-
cific antibodies to PUV or DOBV were detected using ELISA 
IgM and IgG tests as previously described [4]. Patients were 
categorized into the DOBV or PUUV infection groups. 
Biochemical and blood findings were analyzed in 30 HFRS 
patients hospitalized at the University Hospital for Infectious 
Diseases in Zagreb, and their case records were retrospectively 
reviewed. All patients signed an informed consent and the study 
was approved by The University Hospital for Infectious Diseases 
Ethical Committee.  
MeaSureMent of iMMunological ParaMeterS. 
IL-2, sIL-2R, IL-6, sIL-6R and TNF-alpha were measured by 
commercial ELISA kits (QuantikineTM, R&D Systems, Min-
neapolis, USA). According to the manufacturer’s protocols, the 
upper limits for the normal human sera for IL-2 were as follows: 
IL-2 31 pg/mL, IL2R 2132 pg/mL, IL-6 10 pg/mL, sIL-6R 46 
ng/mL and TNF-alpha 39 pg/mL. 
Soluble CD23 was measured by use of ELISA kit (The Binding 
Site Limited, Birmingham, UK). According to the manufactur-
er’s protocol, the range for sCD23 for normal sera was 1-6 pg/L. 
Total IgE was determined using radioimmunosorbent assay (In-
stitute of Immunology, Zagreb, Croatia), as previously described 
20. Total IgE values >120 kU/L were considered elevated. 
StatiStical analySiS. 
Data between groups were compared with the Wilcoxon 
matched pairs test. Pearson product-moment correlation was 
Immunological parameters Day of illness
Serum sCD23 IgE IL-2 sIL-2Rα IL-6 IL-6sR TNF-α Mean Min. Max.
1st 23 41 41 42 40 42 27 10 1 29
2nd 12 16 17 17 18 18 12 19 7 41
No. of sera of HFRS patients
Table 1. The number of sera obtained from HFRS patients two times during the HFRS course and used for the measurement of the immunologi-
cal parameters (sCD23, IgE, IL-2, sIL-2Rapha, IL-6, IL-6 sR and TNF-apha). 
Original Article
RAD CASA - Medical Sciences   -   www.rad-med.com July 2019   -   Vol 537 = 46-4711
used for describing the relationship between the clinical and 
immunological data. 
The statistical software utilized was Stat Soft, Inc. STATISTICA 
for Windows (Computer program manual). Tulsa, OK, USA.
results
Differences in the immunological parameters during the HFRS 
course. 
The results are presented in Figure 1. We did not find elevated 
IL-2 levels in the sera of our HFRS patients. In about 1/4 of 
HFRS patients, we found elevated IL-6 levels in the 1st serum, 
and in the majority of them, IL-6 reached a normal level in the 
second sera. No statistically significant difference was observed in 
IL-2sRa IL-6 IL-6sR sCD23 IgE
Leukocytes (n=37) r=0,62 p=0,0001
(n=37) r=0,36 
p=0,03 - - -







Lymphocytes (n=36) r=-0,45 p=0,006
(n=36) r=-0,63 
p=0,0001 - - -
Basophiles - - - - (n=13) r=0,80 p=0,001





Albumin (n=17) r=-0,58 p=0,01 - - -
(n=19) r=0,49 
p=0,03
Globulins (n=17) r=-0,69 p=0,002 - - -
(n=21) r=-0,55 
p=0,01
g-globulin - (n=20) r=-0,46p=0,0001 - - -






























Total bilirubin (n=27) r=0,64 p=0,0001 - - -
(n=26) r=0,49 
p=0,01
AST (n=27) r=0,71 p=0,0001 - - -
(n=28) r=0,49
p=0,008
g-GT (n=27) r=0,39p=0,05 - - -
(n=26) r=0,58 
p=0,002
Na+ , sodium, Cl-, chloride; AST, aspartate, g-GT, g-glutamil transferase
IL-6 levels between the 1st and the 2nd serum. Only two patients 
had elevated TNF-alpha levels in their sera: one with the severe 
PUU infection and acute renal failure and other with severe 
clinical picture and DOB and leptospira coinfection. On the 
contrary, sIL-2R, sIL-6R and sCD23 levels were elevated in all 
HFRS patients, but we also did not find statistical difference be-
tween 1st and 2nd sera, although we observed higher sCD23 levels 
in the second sera. Total IgE was elevated in about 1/3 of HFRS 
patients in both sera. 
Differences in the immunological parameters between patients with 
PUUV or DOBV infections.
The results are showen in Figure 2. We detected higher IL-6, 
Table 2. Correlation between IL-2sR-alpha, IL-6, IL-6sR, sCD23 and IgE and blood and biochemical findings in sera of patients infected with Puumala or 
Dobrava viruses
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Figure 1. Differences in the immunological parameters during HFRS course. Statisti-
cal difference in the levels of measured parameters between 1st and 2nd sera was not 
observed (Wilcoxon test; significant at p<0.05). The broken line represents the healthy 
controls upper limit for tested parameters.
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Figure 2. Differences in the immunological parameters in patients infected with 
Puumala or Dobrava viruses. A statistically significant higher level of total IgE 
was observed in patients infected with Dobrava virus (Wilcoxon test; significant 
at p<0.05). The broken line represents the healthy controls upper limit for tested 
parameters.
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sIL-2R and sCD23 levels in the sera of patients with DOBV 
infection than in patients with PUUV infection, but a statistical-
ly significant difference was not observed. There was no differ-
ence in TNF-alpha and sIL-6R levels between PUU and DOB 
patients. The total IgE level was elevated in five of the six tested 
patients with DOBV infection and they had a statistically higher 
level of total IgE than patients with PUUV infection. 
The relation between main laboratory biochemical and blood find-
ings and immunological parameters. 
The main altered biochemical and blood findings in HFRS 
patients and their relation to the measured immunological 
parameters are presented in Table 2. We could see that almost all 
listed biochemical and blood parameters in HFRS patients are in 
a positive or negative correlation with sIL-2R-alpha. The levels 
of urea and creatinine, which are the hallmarks of the HFRS 
severity are in positive correlation with sIL-2R-alpha, IL-6, sIL-
6R, and sCD23, while the levels of sodium and chloride are in 
negative correlation with the same parameters, as well as with the 
total IgE. The level of total IgE is in positive or negative cor-
relation with proteins and parameters of liver function. We also 
found a high positive correlation between the total IgE level and 
basophile count. 
diScuSSion 
It is important to determine different immunological parame-
ters which may have a role in the pathogenesis of HFRS. Such 
information may lead to a better understanding of the different 
mechanisms of immunopathogenesis in HFRS. 
This study is among very few studies that analyze differences 
in some immunological parameters in patients with PUUV 
or DOBV infections16, 21 and their relationship with some 
biochemical and blood findings. Previously, we described 
immunophenotypic changes in peripheral blood lymphocytes 
and their relationship with the clinical parameters. We found 
the increased expression of both early and late T cell activa-
tion antigens, e.g. CD25, CD71 and HLA-DR, memory cells 
and sCD23 in seropositive patients, but we did not find any 
significant differences in those parameters between the patients 
infected with PUUV or DOBV16. 
Several authors found an increased level of sIL-2R, which 
was in concordance with HFRS severity17-19. It is known that 
the measurement of IL-2sR is a useful parameter for in vivo 
determination of immune system activation in correlation with 
the clinical picture. IL-2sR-alpha was increased in all Croatian 
HFRS patients and showed a positive or negative correlation 
with the majority of biochemical and blood findings. We real-
ized that the level of IL-2sR was increased when biochemical 
parameters and blood findings, which indicate the progression 
of HFRS, were changed. 
Looking for the difference of IL-2sR levels between patients 
with PUUV and DOBV infections we observed a higher level 
of IL-2sR in patients with DOBV infection. The difference was 
not significant (p<0.07), but we considered that if we had a 
larger population of patients with DOBV infection, we might 
get a statistically significant difference. 
The serum level of IL-2 was not elevated in patients with PUU 
or DOBV infections. It is possible that IL-2sR-alpha could reg-
ulate the activation of T-lymphocytes by competition for IL-2 
and decreased or stopped the proliferation of activated T-lym-
phocytes. Because of the higher levels of IL-2sR-alpha DOBV 
patients and the severe clinical picture, it would be interested 
to analyze T-cell activation and IL-2sR-alpha levels in that 
patients continuously during the HFRS course and in con-
valescence. However, we observed in few HFRS patients that 
IL-2sR-alpha levels decreased from the beginning of HFRS to 
the period of convalescence and that the highest levels we could 
find during the first week of HFRS. (A. Markotić, unpublished 
results). 
The few studies in patients with HTNV or PUUV infec-
tions showed that proinflammatory cytokines IL-1, IL-6, and 
TNF-alpha have a role in HFRS pathogenesis9-12. We found el-
evated levels of IL-6 in about ¼ of our patients and the higher 
levels we observed in patients with DOBV infection. All tested 
patients with PUUV or DOBV infection had elevated levels of 
IL-6sR while TNF-alpha was increased only in few HFRS pa-
tients with the severe clinical picture, as well as in one patient 
with D0BV and leptospira coinfection.
One of the postulates in HFRS pathogenesis is that it is im-
munologically mediated disease with thrombocytopenia and 
vascular dysfunction (mainly due to capillary leakage) as the 
central physiologic derangement. Endothelial cells, togeth-
er with monocytes/macrophages are supposed as the main 
target cells for hantaviruses. Vascular cells are both targets 
for cytokines and a source of cytokines. However, in HFRS, 
monocytes/macrophages also could be an important source of 
secreting cytokines, complement components and coagulation 
factors8. Linderholm et al. found increased levels of TNF-alpha 
in serum samples of patients with acute PUUV infection10. In 
our study, we did not find elevated serum TNF-alpha levels in 
the majority of our HFRS patients, however, we found it in a 
few patients with severe HFRS.
 The sera of majority of our patients were tested on TNF-al-
pha during the second week of HFRS when we can expect a 
decrease of TNF-alpha in HFRS patients. It is probably the 
reason why we did not find more HFRS patients with elevated 
TNF-alpha levels. Our results indicated that we could expect 
increased levels of TNF-alpha in severe HFRS clinical picture. 
In all Croatian HFRS patients, we detected elevated IL-6sR 
levels which were in high positive correlation with urea and cre-
atinine. IL-6 and alpha-chain of IL-6 receptor make a complex 
which binds gp130, a molecule of high transducing affinity for 
IL-6, and enhance IL-6 mediated signal to the target cell. IL-6 
can also induce the liver to enhance the synthesis and secretion 
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of acute phase proteins. 
The role of cytokine production by different cell types involved 
in the pathogenesis of HVBS is not clear. We assume that 
investigations that would allow simultaneous detection of cyto-
kines and cell phenotype could partially clarify this role. Such 
information can lead to a better understanding of the different 
mechanisms of immunopathogenesis in HFRS, as well as differ-
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